Alfa Cytology stands at the forefront of biotechnology, specializing in the development and preclinical research of cancer therapies.
Single B cell technology has emerged as a powerful method for discovering and developing antibodies, particularly in the context of cancers like bladder cancer.
At Alfa Cytology, we offer a comprehensive suite of preclinical services tailored to advance cancer research and drug development.
Oncodesign Services provided valuable support in bioanalysis and dosage for the development.
More than 30 international leading experts has developed proposals to facilitate integration.
* Tick to confirm the Research Use Only (RUO) statement.
Alfa Cytology is dedicated to drug development and preclinical services for bladder cancer.